Business● Low3h ago · Nov 6, 2026, 5:40 AM
Enliven Therapeutics GAAP EPS of -$0.36
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Enliven Therapeutics reported GAAP EPS of -$0.36. This indicates the company's financial performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business13m agoGamco Investors GAAP EPS of $0.57, revenue of $68.5MSeeking Alpha TechBusiness13m agoPDF Solutions reaffirms 20% 2026 growth target while expecting backlog above $271MSeeking Alpha TechBusiness14m agoTKO sets pricing for $1B senior secured notes due 2031Seeking Alpha TechBusiness14m agoInterfor reports Q3 resultsSeeking Alpha Tech